4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-22-018751
Former 10% Holder acquired 2,785,000 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Helix Holdings LLC Former 10% Holder | 2022-04-05 | Conversion | +2,785,000 | 3,215,000 | D | ||
| Derivatives | |||||||
| Helix Holdings LLC Former 10% Holder | 2022-04-05 | Conversion · Class B Ordinary Shares | −2,785,000 | 0 | D | ||
Loading xslF345X03/ownership.xml…